Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk Vivos Therapeutics has a beta of […]
Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent ratings […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant drop in short interest in April. As of April 30th, there was short interest totalling 148,700 shares, a drop of 21.9% from the April 15th total of 190,400 shares. Based on an average daily trading volume, of 708,000 shares, the short-interest ratio […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decrease of 45.1% from the March 15th total of 263,500 shares. Based on an average daily trading volume, of 760,200 shares, the days-to-cover ratio […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decline of 45.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 760,200 shares, the short-interest ratio is […]